Literature DB >> 15200448

Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis.

Laura M Dember1, Erika F Holmberg, James S Kaufman.   

Abstract

BACKGROUND: Previous nonrandomized studies suggest that prophylactic repair of hemodialyisis arteriovenous (AV) graft stenosis reduces thrombosis rates and increases cumulative graft survival. The present study is a randomized trial comparing prophylactic repair of AV graft stenosis with repair at the time of thrombosis.
METHODS: Sixty-four patients with elevated static venous pressure measured in an upper extremity AV graft were randomized to Intervention or Observation. Monthly static venous pressure/systolic blood pressure ratios (SVPR) were determined for all patients throughout the duration of study participation. Patients in the Intervention group underwent angiography and repair of identified stenoses if the monthly SVPR was elevated (>/=0.4). Patients in the Observation group underwent stenosis repair only in the event of access thrombosis or clinical evidence of access dysfunction. The primary end point was access abandonment.
RESULTS: Access abandonment occurred in 14 patients in the Intervention group and 14 patients in the Observation group during the 3.5-year study period. Time to access abandonment did not differ significantly between the treatment groups (hazard ratio for randomization to Intervention 1.75, 95% CI 0.80-3.82, P= 0.16). The proportion of patients with a thrombotic event was greater in the Observation group (72%) than in the Intervention group (44%) (P= 0.04), but overall thrombosis rates were similar in the groups.
CONCLUSION: Compared with a strategy of observation and repair of accesses only in the event of thrombosis, prospective static venous pressure monitoring with prophylactic stenosis repair did not prolong graft survival.

Entities:  

Mesh:

Year:  2004        PMID: 15200448     DOI: 10.1111/j.1523-1755.2004.00743.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

Authors:  Kevin E Chan; Timothy A Pflederer; David J R Steele; Michael P Lilly; T Alp Ikizler; Frank W Maddux; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

2.  Provider visit frequency and vascular access interventions in hemodialysis.

Authors:  Kevin F Erickson; Matthew W Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

3.  Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.

Authors:  Charmaine E Lok; Louise Moist; Brenda R Hemmelgarn; Marcello Tonelli; Miguel A Vazquez; Marc Dorval; Matthew Oliver; Sandra Donnelly; Michael Allon; Kenneth Stanley
Journal:  JAMA       Date:  2012-05-02       Impact factor: 56.272

4.  A Patient with Recurrent Arteriovenous Graft Thrombosis.

Authors:  Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-16       Impact factor: 8.237

Review 5.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

Review 6.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 7.  Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Authors:  Pietro Ravani; Robert R Quinn; Matthew J Oliver; Divya J Karsanji; Matthew T James; Jennifer M MacRae; Suetonia C Palmer; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2016-01-07

Review 8.  Hemodialysis vascular access monitoring: current concepts.

Authors:  Michael Allon; Michelle L Robbin
Journal:  Hemodial Int       Date:  2009-04       Impact factor: 1.812

9.  Outcomes of endovascular intervention for salvage of failing hemodialysis access.

Authors:  Terence Lx Tan; Kyin K May; Peter A Robless; Pei Ho
Journal:  Ann Vasc Dis       Date:  2011-06-02

Review 10.  The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.

Authors:  Braden J Manns; David C Mendelssohn; Kenneth J Taub
Journal:  Int J Health Care Finance Econ       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.